HOLLAND & KNIGHT LLP

Lobbying for ALKERMES, INC. · Biopharmaceutical company

Filing 4th Quarter - Termination

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 13, 2026

Income

$20,000.00

What the client paid this registrant for the period.

Client based in

Massachusetts

Representation ended

Dec 31, 2025

The registrant reported terminating its work for this client.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Taxation/Internal Revenue Code

Tax Reform - Restoring the Orphan Drug Tax Credit.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.